These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12434018)

  • 1. In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted?
    Ribeiro RM; Mohri H; Ho DD; Perelson AS
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15572-7. PubMed ID: 12434018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy.
    Mohri H; Perelson AS; Tung K; Ribeiro RM; Ramratnam B; Markowitz M; Kost R; Hurley A; Weinberger L; Cesar D; Hellerstein MK; Ho DD
    J Exp Med; 2001 Nov; 194(9):1277-87. PubMed ID: 11696593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: impact of highly active antiretroviral therapy.
    Dyrhol-Riise AM; Ohlsson M; Skarstein K; Nygaard SJ; Olofsson J; Jonsson R; Asjö B
    Clin Immunol; 2001 Nov; 101(2):180-91. PubMed ID: 11683577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion.
    Di Mascio M; Sereti I; Matthews LT; Natarajan V; Adelsberger J; Lempicki R; Yoder C; Jones E; Chow C; Metcalf JA; Sidorov IA; Dimitrov DS; Polis MA; Kovacs JA
    J Virol; 2006 Mar; 80(6):2665-74. PubMed ID: 16501076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients.
    Lempicki RA; Kovacs JA; Baseler MW; Adelsberger JW; Dewar RL; Natarajan V; Bosche MC; Metcalf JA; Stevens RA; Lambert LA; Alvord WG; Polis MA; Davey RT; Dimitrov DS; Lane HC
    Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13778-83. PubMed ID: 11095734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral therapy corrects HIV-1-induced expansion of CD8+ CD45RA+ CD2-) CD11a(bright) activated T cells.
    Yin L; Rodriguez CA; Hou W; Potter O; Caplan MJ; Goodenow MM; Sleasman JW
    J Allergy Clin Immunol; 2008 Jul; 122(1):166-72, 172.e1-2. PubMed ID: 18538835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV.
    Kovacs JA; Lempicki RA; Sidorov IA; Adelsberger JW; Herpin B; Metcalf JA; Sereti I; Polis MA; Davey RT; Tavel J; Falloon J; Stevens R; Lambert L; Dewar R; Schwartzentruber DJ; Anver MR; Baseler MW; Masur H; Dimitrov DS; Lane HC
    J Exp Med; 2001 Dec; 194(12):1731-41. PubMed ID: 11748275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover.
    Wolthers KC; Bea G; Wisman A; Otto SA; de Roda Husman AM; Schaft N; de Wolf F; Goudsmit J; Coutinho RA; van der Zee AG; Meyaard L; Miedema F
    Science; 1996 Nov; 274(5292):1543-7. PubMed ID: 8929418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2 immunotherapy exerts a differential effect on CD4 and CD8 T cell dynamics.
    Marchetti G; Meroni L; Molteni C; Bandera A; Franzetti F; Galli M; Moroni M; Clerici M; Gori A
    AIDS; 2004 Jan; 18(2):211-6. PubMed ID: 15075538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover.
    Anthony KB; Yoder C; Metcalf JA; DerSimonian R; Orenstein JM; Stevens RA; Falloon J; Polis MA; Lane HC; Sereti I
    J Acquir Immune Defic Syndr; 2003 Jun; 33(2):125-33. PubMed ID: 12794543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).
    Hazenberg MD; Stuart JW; Otto SA; Borleffs JC; Boucher CA; de Boer RJ; Miedema F; Hamann D
    Blood; 2000 Jan; 95(1):249-55. PubMed ID: 10607709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of HIV viral load and CD4 count on proliferation of naive and memory CD4 and CD8 T lymphocytes.
    Srinivasula S; Lempicki RA; Adelsberger JW; Huang CY; Roark J; Lee PI; Rupert A; Stevens R; Sereti I; Lane HC; Di Mascio M; Kovacs JA
    Blood; 2011 Jul; 118(2):262-70. PubMed ID: 21562041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling deuterated glucose labeling of T-lymphocytes.
    Ribeiro RM; Mohri H; Ho DD; Perelson AS
    Bull Math Biol; 2002 Mar; 64(2):385-405. PubMed ID: 11926122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen.
    Sachsenberg N; Perelson AS; Yerly S; Schockmel GA; Leduc D; Hirschel B; Perrin L
    J Exp Med; 1998 Apr; 187(8):1295-303. PubMed ID: 9547340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.
    Dyrhol-Riise AM; Voltersvik P; Olofsson J; Asjö B
    AIDS; 1999 Dec; 13(17):2365-76. PubMed ID: 10597778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection.
    Amu S; Lantto Graham R; Bekele Y; Nasi A; Bengtsson C; Rethi B; Sorial S; Meini G; Zazzi M; Hejdeman B; Chiodi F
    Medicine (Baltimore); 2016 Jun; 95(23):e3738. PubMed ID: 27281071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy.
    Fleury S; Rizzardi GP; Chapuis A; Tambussi G; Knabenhans C; Simeoni E; Meuwly JY; Corpataux JM; Lazzarin A; Miedema F; Pantaleo G
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5393-8. PubMed ID: 10805798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulation.
    Cohen Stuart JW; Hazebergh MD; Hamann D; Otto SA; Borleffs JC; Miedema F; Boucher CA; de Boer RJ
    J Acquir Immune Defic Syndr; 2000 Nov; 25(3):203-11. PubMed ID: 11115950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.
    Kolber MA
    AIDS; 2008 Oct; 22(15):1937-41. PubMed ID: 18784457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.